Arbutus Biopharma (ABUS) Cash & Current Investments (2010 - 2026)
Arbutus Biopharma (ABUS) recorded Cash & Current Investments of $92.63 million in Q2 2026, down 5.6% from $98.09 million a year earlier and down 2.7% from the prior quarter.
Powered by 
Analysis
Arbutus Biopharma (ABUS) Cash & Current Investments (2010 - 2026) Analysis & Trends
At the end of FY2025, Arbutus Biopharma reported Cash & Current Investments of $91.47 million, down 25.4% from FY2024.
- Annual Cash & Current Investments has declined for four straight years, with a five-year compound annual growth rate of -5.8% (FY2020 to FY2025).
- Across earlier years, Cash & Current Investments came in at $122.62 million in FY2024 (-2.7%), $126 million in FY2023 (-14.2%), $146.91 million in FY2022 (-5.4%) and $155.32 million in FY2021 (+26.0%).
- Quarterly Cash & Current Investments has ranged from $91.47 million in Q4 2025 to $165.48 million in Q1 2022 over the past five years.
- On a year-over-year basis, Cash & Current Investments has declined for 12 consecutive quarters, with an average decline of 15.5% over the last eight quarters.
- Peak year-over-year performance for Cash & Current Investments in the last five years was growth of 91.6% in Q2 2022, against a decline of 30.9% in Q2 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at $95.23 million (Q1 2026), $91.47 million (Q4 2025) and $93.7 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 20.76 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 7.14 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 9.92 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 4.97 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 11.70 Bn |
| 10 | Arbutus Biopharma | 879.47 Mn | 506.45 Mn | - | 92.63 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 92.63 Mn |
| Mar 31, 2026 | 95.23 Mn |
| Dec 31, 2025 | 91.47 Mn |
| Sep 30, 2025 | 93.70 Mn |
| Jun 30, 2025 | 98.09 Mn |
| Mar 31, 2025 | 112.71 Mn |
| Dec 31, 2024 | 122.62 Mn |
| Sep 30, 2024 | 127.79 Mn |
| Jun 30, 2024 | 141.99 Mn |
| Mar 31, 2024 | 129.24 Mn |
| Dec 31, 2023 | 126.00 Mn |
| Sep 30, 2023 | 134.18 Mn |
| Jun 30, 2023 | 152.48 Mn |
| Mar 31, 2023 | 146.73 Mn |
| Dec 31, 2022 | 146.91 Mn |
| Sep 30, 2022 | 134.72 Mn |
| Jun 30, 2022 | 150.20 Mn |
| Mar 31, 2022 | 165.48 Mn |
| Dec 31, 2021 | 155.32 Mn |
| Sep 30, 2021 | 121.40 Mn |
API Access
Arbutus Biopharma Cash & Current Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=ABUS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-current-investments", "ticker": "ABUS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=ABUS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();